ArticlePloS one2019

Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience.

Alberto Benazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.